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kinetic of hs-cTnT and a negative copeptin, only 2 (3.8%) had a critical ste-
nosis (NPV 95%) both related to in stent restenosis (table 1). 
Conclusion In patients with pre-existing CAD, once ACS is excluded,
copeptin provides a useful additional triage strategy in acute chest pain to
exclude severe coronary stenosis or stenosis inducing myocardial
ischemia.
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Background In submassive pulmonary embolism (PE), when a right ven-
tricular (RV) dysfunction (RVD) is present, the benefit of fluid expansion
(FE) is questionable. The Franck-Starling law suggests that the reduction of
the RV overload may enhances the RV systolic function. 
Purpose The aim of our study was to compare the effects of a diuretic
treatment (DT) versus FE in patients hospitalized for normotensive PE with
RVD. 
Methods We performed a prospective study. Consecutive patients hospi-
talized for normotensive PE were treated with diuretic (40mg IV furosemide
at admission) or FE (500cc of sodium chloride infusion during four hours at
admission). The primary endpoint was the timing for normalization of BNP
and troponin Ic values. The secondary endpoints were variations of clinical
and RV echographic parameters. 
Results Forty five patients were included. Timing for Troponin and BNP
normalization was 60,7±28 hours in the DT versus 93,2±42 hours in the FE
group (figure 1, p=0.02). Normalization of RV dilatation took 91,7±14,2 hours
in the DT group versus 108,4±17,5 hours in the FE group (p=0.01). Norma-
lization of the RVD took 81,2±18 hours in the DT group versus 94,9±13,1
hours in the FE group (p=0.03). 
Conclusion In the early management of normotensive PE with RVD, DT
may be superior to FE in order to improve the time to normalization of
biological and echocardiographic markers.
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Abstratct 0291 – Table: Predictive values 
 Sensitivity Specificity Positive predictive value Negative predictive value
 hs-cTnT <14 ng/L and <50% 
change at 3 hours
n=91
0.22
IC (0.028-0.6)
0.73
IC(0.604-0.83)
0.10
IC(0.012-0.317)
0.87
IC (0.755-0.947)
Copeptin <10 pmol/L + hs-
cTnT <14 ng/L
n=71
0.75
IC(0.428-0.945)
0.6
IC (0.476-0.715)
0.24
IC(0.118-0.412)
0.93
IC(0.817-0.986)
Copeptin<10 pmol/L + negative 
kinetic of hs-cTnT at 3 hours
n=52
0.79
IC (0.4-0.972)
0.54
IC (0.418-0.669)
0.19
IC (0.08-0.352)
0.95
IC (0.823-0.994)
Abstract 0358 – Figure 1
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